What is the normal endometrial thickness in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Endometrial Thickness in Women

Normal endometrial thickness is ≤4 mm in postmenopausal women and varies by menstrual cycle phase in premenopausal women. 1

Endometrial Thickness by Menopausal Status

Postmenopausal Women

  • An endometrial thickness ≤4 mm in postmenopausal women conveys a negative predictive value for endometrial cancer of nearly 100% 1
  • Endometrial thickness ≥5 mm in postmenopausal women generally prompts evaluation by endometrial tissue sampling, particularly in the presence of vaginal bleeding 1
  • In asymptomatic postmenopausal women (without vaginal bleeding), a higher threshold of >11 mm may be more appropriate for recommending biopsy 2
  • Body weight correlates with endometrial thickness in postmenopausal women with measurements <5 mm 3

Premenopausal Women

  • Endometrial thickness varies throughout the menstrual cycle:
    • Early proliferative phase: 4-7 mm
    • Late proliferative phase: 7-11 mm
    • Secretory phase: 7-14 mm

Clinical Implications

When to Investigate Endometrial Thickness

  • Postmenopausal women with any abnormal vaginal bleeding should be evaluated regardless of endometrial thickness 1
  • Endometrial thickness ≥5 mm in postmenopausal women with bleeding requires tissue sampling 1
  • Endometrial thickness ≥11 mm in asymptomatic postmenopausal women warrants consideration of biopsy (risk of cancer approximately 6.7%) 2
  • Endometrial thickness ≥11 mm in asymptomatic postmenopausal women carries increasing risk with age (from 4.1% at age 50 to 9.3% at age 79) 2

Hormone Replacement Therapy Effects

  • Hormone replacement therapy increases endometrial thickness 4
  • Different evaluation thresholds may apply based on hormone status:
    • Women receiving unopposed estrogen or continuous estrogen and progestogen with thickness 0.8-1.5 cm should undergo biopsy 4
    • Any patient with endometrial thickness ≥1.5 cm should undergo histologic diagnosis regardless of hormone status 4

Diagnostic Considerations

  • Transvaginal ultrasound (TVUS) is the first-line screening test for evaluating endometrial thickness 1
  • Three-dimensional ultrasound measurements of endometrial volume may be superior to thickness measurements for detecting endometrial cancer in symptomatic women 5
  • Endometrial sampling devices like Pipelle (99.6% sensitivity) and Vabra (97.1% sensitivity) are highly effective for detecting endometrial carcinoma 1

Common Pitfalls

  • Failing to evaluate postmenopausal women with vaginal bleeding regardless of endometrial thickness
  • Using the same endometrial thickness threshold for symptomatic and asymptomatic postmenopausal women
  • Not accounting for hormone replacement therapy when interpreting endometrial thickness
  • Not considering patient's age and body weight, which can influence normal endometrial thickness values

References

Guideline

Diagnostic Evaluation of Endometrial Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2004

Research

The diagnostic value of endometrial thickness and volume measurements by three-dimensional ultrasound in patients with postmenopausal bleeding.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.